I am a
Home I AM A Search Login

Papers of the Week

2023 Feb




Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials.


Lipton RB, Blumenfeld A, Jensen CM, Croop R, Thiry A, L'italien G, Morris BA, Coric V, Goadsby PJ
Cephalalgia. 2023 Feb; 43(2):3331024221141686.
PMID: 36739511.


This post-hoc analysis from three phase 3 treatment trials of rimegepant 75 mg – an oral small molecule calcitonin gene-related peptide receptor antagonist for acute and preventive treatment of migraine – assessed efficacy in adults with migraine based on triptan treatment experience.